Here are some of the latest news bits.
From AIDSMeds
February 19, 2008
Starting Treatment With Higher CD4s Cuts Death Rate
People who start antiretroviral treatment with CD4 counts above 350 have the lowest risk of disease progression and death compared with people who start at CD4 counts below 350, say the authors of a study published in the February 1 issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS) and reported by AIDSmap.
February 15, 2008
http://www.aidsmeds.com/articles/hiv_ai ... 4063.shtml
HIV Treatment Improves, but Doesn’t Restore, B Cells
Most types of B cells return to normal levels within 12 months after starting antiretroviral therapy, leading to a partial—but incomplete—recovery of the immune system, say researchers of a new study published in the Journal of Infectious Diseases.
February 14, 2008
http://www.aidsmeds.com/articles/hiv_ai ... 4044.shtml
Suppressing HIV Improves Kidney Function
Reducing viral load using antiretroviral therapy can greatly improve renal function in people with HIV and kidney disease, according to a new study published in the February 19 issue of AIDS.
February 13, 2008
http://www.aidsmeds.com/articles/hiv_ai ... 4037.shtml
Acyclovir Doesn’t Reduce HIV Infection Risk in HSV-2-Positive People
The anti-herpes drug acyclovir did not reduce the risk of acquiring sexually transmitted HIV when given to men and women infected with herpes simplex virus-2 (HSV-2), according to the authors of a study reported last week at the 15th CROI in Boston.
http://www.aidsmeds.com/articles/hiv_ac ... 4029.shtml
